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Abstract 
Background  
There is limited contemporary population based evidence on adverse birth outcomes and 
pregnancy related complications for women with inflammatory bowel disease (IBD). This 
study provides such estimates of these risks and assesses variation by IBD type and surgical 
interventions. 
 
Methods 
We calculated the proportion of pregnancies in women with and without IBD between 1997 
and 2012 throughout England using linked primary (Clinical Practice Research Datalink-
CPRD) and secondary care (Hospital Episode Statistics-HES) data. Risk of pregnancy related 
complications and adverse birth outcome in women with Crohn’s Disease-CD and Ulcerative 
Colitis-UC were compared to risks in women without IBD using odds ratios (OR). 
 
Results 
Of 364,363 singleton pregnancies resulting in live or stillbirths 1,969 (0.5%) were in women 
with IBD. Women with CD were more likely to have pre-term births (OR=1.42 95%CI;1.12-
1.79), babies with low birth weights (OR=1.39;1.05-1.83) and postpartum haemorrhage 
(OR=1.27;1.04-1.55) whereas women with UC were only at increased risk of pre-term births 
with an absolute risk difference of <2.7%. These risks remained independent of caesarean 
section (CS). Prior surgery for IBD did not increase risk of adverse birth outcomes or 
pregnancy related complications compared to cases without surgery, however women with 
IBD were more likely to have an elective CS.  
 
Conclusion 
Women with CD, have increased risks of some specific pregnancy related complications and 
adverse birth outcomes which are independent of caesarean section, however the absolute 
risk differences are small indicating that most women with IBD will have an uncomplicated 
pregnancy.  
 
 Keywords: inflammatory bowel disease, adverse birth outcomes 
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Introduction  
The incidence of inflammatory bowel disease (IBD) peaks around women’s reproductive age 
and it has been linked to increased risks of pre-term birth and low birth weight which may 
lead to perinatal mortality.
1
 However the results from previous studies are inconsistent 
perhaps because most have been inadequately powered to provide reliable or precise 
figures.
2-6
 Even a meta-analysis by Cornish et.al
7
 which found 97% and 34% relative 
increases in the risk of pre-term births among those diagnosed with Ulcerative Colitis (UC) 
and Crohn’s Disease (CD) respectively only included 1831 births to mothers with UC and 
1005 to mothers with CD. This meta-analysis also reported a statistically significant 3-fold 
increase in the incidence of low birth weight among the children of mothers with CD 
compared to non-IBD controls, though there was no significant increase in low birth weight 
for children of mothers with UC. It is also not clear how adverse birth outcome varies by 
various mode of deliveries among women with IBD which may be medically driven because 
of complications related or unrelated to IBD. Furthermore, of studies that have found a 
significant positive association between IBD and caesarean section
3, 5-8
 most were unable to 
distinguish between the types of caesarean section (emergency versus elective). Finally, the 
potential impact of prior surgical intervention among women with IBD on these pregnancy 
outcomes also remains unknown. Accurate estimates of the risk of adverse birth outcomes 
and pregnancy related complications that are generalizable to the majority of pregnancies in 
women with IBD will aid both women and practitioners in better decision making. Therefore 
the aim of this study was to look at the contemporary risk of pregnancy associated 
complications and adverse birth outcomes among women diagnosed with IBD and assess its 
variation by IBD type and surgical intervention.  
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Method 
Study population 
We used the Clinical Practice Research Datalink (CPRD) 
9
 which is a large longitudinal UK 
database that contains the anonymised primary care records of patients in computerised form. 
The CPRD includes practices where staff have been trained to enter data to the necessary 
standard for research, and identifies the date at which this standard is reached. All patients 
within a participating practice are automatically included. Data from around 53% of the 
CPRD practices are also linked to Hospital Episode Statistics (HES)
10, 11
 data which contains 
more detailed information on all hospitalisations in England, including all discharge 
diagnoses and procedures. As HES only covers English hospitals, practices from Northern 
Ireland, Wales and Scotland are excluded. The linked portion of the CPRD has been shown to 
be similar in terms of age and sex distribution to the UK population published by the Office 
for National Statistics (ONS)
12
. Diagnoses of IBD
13
 in primary care and delivery/birth 
information in HES maternity data
14
 have been validated to external sources with positive 
predictive values of 92% and 93% respectively.  
 
Defining cases 
We used as our source population the entirety of CPRD records for practices linked to HES 
data, during the period for which this linkage was available (1997-2012). Women in this 
population aged 15-44 years with HES-recorded singleton pregnancies ending in a live birth 
or a stillbirth between 1997 and 2012 were identified from our study population. Pregnant 
women were defined as having IBD during pregnancy if they had ever had a diagnosis before 
delivery or if they had a diagnosis after delivery but a prescription of 5-ASA at some point 
before delivery. Information on the IBD diagnosis was extracted using both primary and 
secondary care data. Pregnant women with IBD were classified as having CD if they had 
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diagnoses specifying this condition regardless of whether they also had diagnoses of UC, as 
having UC if they had recordings of UC but not CD, and as having unclassified IBD if their 
coding for IBD did not specify CD or UC.  
 
For pregnant women with IBD, we also extracted information on surgical interventions that 
included women undergoing small bowel (e.g. excision of lesion of ileum), large bowel (e.g. 
colectomy), perianal surgery (e.g. Perianal excision lesion of rectum) or pouch surgery (e.g. 
anastomosis of ileum to rectum) using their both primary and secondary care records (code 
list available on request). In order to correctly ascertain pouch surgeries among women with 
UC, we also reviewed their surgical records. We considered women as having surgical 
intervention for IBD if they had a record for a relevant surgical procedure at any point from 
diagnosis up to their date of delivery. Our control population was pregnant women without a 
diagnosis of IBD in their primary or secondary care records. 
 
Defining outcomes  
From HES, we extracted information on pregnancy related complications (postpartum 
haemorrhage, antepartum haemorrhage, gestational diabetes, venous thromboembolism and 
pre-eclampsia/eclampsia) using previously established methodology.
15, 16
 Mode of delivery 
was categorised as normal vaginal delivery, assisted vaginal delivery (forceps, breech or 
vacuum), emergency and elective caesarean. We also extracted information on adverse birth 
outcomes (pregnancies resulting in pre-term births (<37 weeks of gestation), post-term births 
(>41 weeks), stillbirths or infants born with low birth weight (<2500 grams)).  
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Defining maternal co-variables 
For each pregnancy, information on maternal factors during or before pregnancy was 
extracted from the patient’s medical record. Maternal age at delivery was considered in 5-
year age bands. Information on body mass index (BMI) categorised as normal weight 
(18.5kg/m
2
 ≤ BMI<25kg/m2), underweight (BMI<18.5kg/m2), overweight (25kg/m2 < 
BMI<30kg/m
2
) and obese (BMI≥30kg/m2) using the latest measure recorded by the general 
practitioner before the date of conception, smoking status categorised as current smoker or 
non-current smoker using the latest measure recorded by the general practitioner before 
delivery and ethnicity (as recorded in HES and grouped into white or non-white) was also 
extracted. Pregnant women were also defined as having diabetes in pregnancy (either pre-
existing or gestational) if it was recorded either in primary or secondary care data, or if a 
woman received a prescription for anti-diabetic medication (insulin or oral hypoglycaemic 
agents) at any time before delivery.   
 
Statistical analysis  
We calculated the proportions of pregnancies affected for all pregnancy related complications 
and adverse birth outcomes among those with and without IBD.  These estimates were then 
stratified by IBD type (CD or UC) and perianal disease. Since only a small proportion of IBD 
in pregnant women was unclassified, their segregated results are not presented. We used 
logistic regression models to calculate the odds ratios (OR) and 95% confidence interval 
(95% CI) for the associations between IBD diagnosis and pregnancy related complications 
and adverse birth outcomes. These estimates were adjusted for maternal age, BMI, smoking 
status, calendar year at delivery (categorised to birth at 1997-2001, 2002-2006 and 2007-
2012), diabetes and ethnicity. Missing information on BMI, smoking status and birth weight 
was grouped into separate categories and included in the analyses. In order to assess the 
7 
 
extent to which the adverse birth outcomes (e.g. pre-term births) were medically driven (via 
elective caesarean sections), we carried out subgroup analyses among women who underwent 
normal vaginal or assisted delivery, elective caesarean section, emergency caesarean section 
and excluding women who underwent elective caesarean section. Similarly, to examine if the 
association between IBD and low birth weight is independent of the length of gestation, we 
analysed the risk of low birth weight among women with term births only. Among those 
diagnosed with IBD (UC or CD), we assessed the association of previous surgery for IBD 
with the risk of pregnancy related complications and adverse birth outcomes compared to 
women without such previous surgery. This analysis was then further stratified by disease 
type (UC and CD) and type of surgery. We also assessed the potential impact of pouch 
surgery among women with UC on pregnancy outcomes by restricting to those women in our 
analysis. For the purpose of this study, the categorisation of surgical intervention was not 
considered as mutually exclusive (i.e. if a woman had undergone more than one type of 
surgery prior to a pregnancy this was included in the analysis). As we did not have 
information on the severity of disease, we identified IBD case prescribed steroids at any point 
in time during pregnancy to assess the impact of disease activity on adverse outcomes. A 
clustering term was fitted in the models to account for women experiencing more than one 
pregnancy during the study period. All analyses were carried out using Stata MP 13.0 (Stata 
Corp., College Station, TX, USA). 
 
Ethical consideration  
This study was approved by the CPRD’s scientific advisory committee (ISAC) (reference 
number= 10_193)  
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Results 
Study population  
Among 276,719 women in our study population, there were 364,363 singleton pregnancies 
resulting in a live birth or a stillbirth. The proportion of pregnancies in women who had IBD 
diagnosed at some point before delivery was 0.5% (n=1,969). The majority (n=1,664 (85%)) 
of IBD diagnoses were made more than one year before delivery. Of all women with IBD, 
51% (n=1,002) had CD and 45% (n=884) had UC with the remainder (n=83, 4%) of cases 
being of unclassified IBD type. Table 1 shows the maternal characteristics of mothers with 
and without IBD. Compared to controls, pregnant women with IBD were slightly older and 
more likely to be underweight particularly those with CD. Those with UC had a higher 
prevalence of diabetes and were less likely to be smokers compared to the control population 
whereas women with CD were more likely to be smokers. These differences were statistically 
significant (p-value <0.01).  Overall, we found modestly increased risks of pregnancy related 
complications and adverse birth outcomes among pregnant women with IBD compared to the 
control population (Table 2). The risk for gestational diabetes, pre-eclampsia/eclampsia, pre-
term birth and low birth weight was further increased among cases prescribed steroids during 
pregnancy (supplementary table 1). 
 
Adverse pregnancy and birth outcome among CD 
The absolute risks of antepartum and postpartum haemorrhages among those with CD were 
5.2% and 12.3% respectively. This corresponded to a 0.5% and 2.6% absolute excess risk 
respectively compared to the control population (Table 2). Compared to controls, women 
with CD were more like to undergo elective caesarean section with an absolute risk of 17.2% 
vs 9.7%, i.e. almost 2-fold (Adjusted odds ratio (AOR)=1.97; 95%CI 1.61-2.40) whereas the 
increase was more modest for emergency caesarean section (AOR=1.31; 95%CI 1.08-1.59) 
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(Table 3). Higher risk of assisted deliveries (AOR=2.61; 95%CI 1.50-4.53) and elective 
caesarean section (AOR=6.20 95%CI 3.82-10.04) was observed for those with perianal 
crohn’s compared to controls. We did not find CD to be associated with a higher risk of 
stillbirths; however women with CD were 42% (AOR=1.42; 95%CI 1.12-1.80) and 40% 
(AOR=1.40 95%CI 1.06-1.85) more likely to deliver pre-term (gestation<37 weeks) and have 
smaller babies (birth weight<2500 grams) respectively compared to the control population. 
Even among women with CD delivering at term, we found an increased risk of having babies 
with low birth weight, although the association was not statistically significant (AOR=1.37 
95%CI 0.92-2.04). We also found that mothers with CD had babies with a mean weight 80 
grams lower (95%CI -40 to -120) compared to those without IBD. Finally the positive 
associations observed between CD and postpartum haemorrhage, pre-term birth and low birth 
weight remained when we excluded pregnant women who underwent caesarean section 
(Figure 1) and excluded CD cases with perianal disease (supplementary table 2).  
 
Adverse pregnancy and birth outcome among UC 
Among pregnant women with UC, we did not observe a significantly increased risk of 
antepartum haemorrhage, postpartum haemorrhage, pre-eclampsia/eclampsia or emergency 
caesarean section compared to women without IBD (Table 2). The absolute rate of elective 
caesarean section was higher among those with UC compared to controls (13.7% versus 
9.7%); however this increased risk was not statistically significant (Table 2 and Table 3). We 
observed that women with UC were 33% more likely to have pre-term births (AOR=1.33 
95%CI 1.06-1.67, absolute risk 8.5% in UC vs 6.5% in controls). This effect was also 
statistically significant when we excluded women who underwent caesarean sections (Figure 
2). Finally, pregnant women with UC were not at a higher risk of stillbirths or giving birth to 
babies with low birth weight. There was also no statistically significant difference in the 
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mean birth weight among cases and controls (Mean difference=-28 grams 95%CI -13 to 70) 
(Table 2).     
 
Surgical intervention for IBD and adverse pregnancy and birth outcomes 
Some form of surgical intervention for IBD occurred before 344 (17.4%) of the deliveries. 
We found no increased risk of pregnancy related complications and adverse birth outcomes 
occurring in pregnancies following surgical intervention compared to those with IBD without 
surgical intervention (Table 4). However, those who underwent any surgical procedure for 
IBD were 3 times more likely to undergo elective caesarean section (absolute risk=28.5%; 
AOR=3.15 95%CI 2.23-4.45) compared to those IBD cases without any surgical intervention 
(absolute risk=12.4%).  
 
For CD, our results for postpartum haemorrhage, mode of delivery and length of gestation 
remained broadly similar when we stratified our analysis by type of surgery except for 
perianal surgery which was associated with a 4-fold (AOR=4.27 95%CI2.38-7.68) increase in 
risk of elective caesarean section (Supplementary table 3). Women with UC who under-went 
surgical intervention were 13 times (Absolute risk=51% AOR=13.01 95%CI 5.68-29.80) 
more likely to undergo elective caesarean section compared to those without surgical 
intervention. This association was even stronger when we restricted our analysis to those who 
underwent pouch surgery (Supplementary table 4).   
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Discussion 
Main findings 
In this large cohort study of more than 360,000 singleton pregnancies resulting in a live birth 
or a stillbirth, we have provided population-based estimates of the proportion of such 
pregnancies complicated by IBD that have pregnancy related complications and adverse birth 
outcomes. Around 0.5% of these pregnancies were among women who have IBD, of which 
more than half had CD. Women with CD were at increased risk of postpartum haemorrhage, 
caesarean section, pre-term birth and low birth weight compared to those without an IBD 
diagnosis with the absolute excess risk ranging between 1.6% (low birth weight) and 2.6% 
(pre-term birth). Given baseline risks of 4.5% low birth weight and 6.5% preterm birth in the 
general population (without IBD), these increases are modest. Women with CD were also 
more likely to undergo both elective and emergency caesarean sections. The increased risk of 
pre-term birth and low birth weight among women with CD remained when we excluded 
women who underwent caesarean section. In contrast, those with UC were only at an 
increased risk of pre-term delivery and this association remained statistically significant when 
we excluded those who underwent caesarean section delivery. We found no increased risks of 
pregnancy related complications and adverse birth outcomes among those with prior surgical 
intervention for IBD compared with those with IBD but without a history of surgical 
intervention. However, there was an increased risk of elective caesarean section associated 
with a history of surgical intervention which was more apparent in the UC group.  
 
Strengths and limitations  
We have conducted one of the largest single studies yet to determine the risk of pregnancy 
related complications and adverse birth outcomes in women with IBD. Our study used an 
open cohort approach, with prospectively collected data and utilised information from linked 
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primary and secondary care data sources from across England covering 3% of the total UK 
population with a similar age and sex distribution to the population as a whole.
17
 Our study 
findings should therefore not only be generalisable to singleton pregnancies resulting in a live 
birth or a stillbirth in England but also to other developed nations with similar health care 
systems and baseline incidence of adverse outcome. As HES is the primary source of 
maternity statistics in England and its birth outcomes have been externally validated with 
high accuracy,
14
 we believe that under recording of birth outcomes and differential recording 
of adverse pregnancy related complications/outcomes between women with and without 
diagnosed IBD is unlikely. Our use of linked data from both primary and secondary care also 
allows better adjustment for important confounding factors such as BMI, smoking status and 
maternal diabetes. 
 
A potential weakness of this study is that since we used anonymised patient records and had 
no direct access to the patients, we were dependent on family doctors entering data accurately 
in CPRD. However, the diagnosis of IBD has been previously validated in UK electronic 
general practice data with a high degree of accuracy so we think it unlikely that there is major 
error in our findings due to misattribution of the diagnosis of IBD.
13
 We also acknowledge 
that there are other commonly investigated outcomes (spontaneous abortion, APGAR score 
and neonatal death) which we were not able to assess in our study due to the lack of complete 
and reliable data. However, previously our group found very limited increased risk of major 
congenital anomalies in children born to mothers with IBD
18
 using another similar dataset 
which had linked mother baby information. 
Interpretation in the context of previous literature 
Our finding of increased risk of pre-term birth among babies born to mothers with CD is 
consistent with most previous studies although the magnitude of the effect that we observed 
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in our study was slightly lower than most
2, 4-6
 but not all previous studies.
19-21
  It should be 
noted that the greatest apparent magnitudes (more than 2-fold increased risk compared to 
controls) for this association have been in general reported by small often single centre 
studies
2, 4-6
 based on 38 to 177 cases. However, the few large multicenter population based 
studies with more than 500 cases are more similar in their findings to our own.
19, 20, 22
  
Similarly, our finding of an increased risk of having babies with low birth weight among CD 
mothers is in line with the existing literature.
19, 20
 We showed that pregnant women with UC 
are more likely to have pre-term birth compared to the control population whereas the risk of 
having babies with low birth weight is similar between cases and controls. This finding is 
supported by a number of previous studies
2, 4, 23
 and a meta-analysis.
7
 In contrast, Dominitz et 
al
5
 in their multicenter hospital based study, found no association between prematurity and 
UC which may be due to the database and methodology used to define their exposure. For 
instance, the authors established the presence or absence of IBD through the review of 
diagnoses listed in the discharge record from hospitalisation associated with birth leading to 
under ascertainment of IBD cases. This is evident by their much lower prevalence of IBD in 
pregnancy (0.03%) compared to our own (0.5%). Moreover, the IBD definition was not 
validated in this previous study which may have led to misclassification between CD and UC 
given that the study also reported a much higher increased risk (4-fold) of pre-term birth 
associated with CD. Similarly, Bortoli et al
21
 found no evidence of pre-term birth among 
those with UC or CD which may be attributed to their small number of cases and high 
dropout rate which may have biased their estimates. Our stratified analyses by mode of 
delivery show evidence that prematurity and babies born with low birth weight observed 
among IBD cases may be independent of factors and/or complications leading to medically 
driven caesarean section for which further studies are needed. 
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Our finding of higher proportions of women with IBD undergoing caesarean sections 
particularly among those with CD is not new and has been previously demonstrated.
24
 Of 
interest is the fact that the majority of the caesarean sections were elective. Whilst clinical 
guidelines
25, 26
 only support caesarean section delivery among those with complicated IBD 
(those with severe disease, with perianal disease and some women with pouches) and the risk 
of readmissions post-caesarean sections are higher compared to those who undergo normal 
vaginal delivery,
27
 controversies exist over the most appropriate mode of delivery among 
pregnant women with IBD. For instance, there is evidence suggesting that the risk of 
incontinence and sphincter tear is greater among those who undergo normal vaginal delivery 
than in caesarean section.
7
 On the other hand there is evidence suggesting that refraining 
from vaginal delivery does not necessarily protect against incontinence
28
 and that vaginal 
delivery does not seem to substantially influence pouch function and quality of life.
29
 
Presumably, previous abdominal surgery affects the choice of delivery method by both the 
woman and clinicians involved in their antenatal care as our study demonstrated that a higher 
proportion of women who had prior surgery for IBD underwent elective caesarean sections. 
This effect was more prominent among those with UC even after excluding women who had 
pouch surgery. In order to better understand the relationship between caesarean section and 
IBD, it may be important to explore the primary indication for caesarean section (IBD versus 
other medical causes) for which we do not have data. 
 
We found that among those who underwent surgical intervention prior to delivery, there was 
no increased risk of adverse birth outcomes compared to those with IBD without surgical 
intervention. Whilst these findings may be reassuring, Stephansson et al
20
 reported a more 
than 53% increased risk of pre-term birth among Swedish and Danish pregnant women with a 
history of CD related surgery. This may be due to the fact that this previous study was based 
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on inpatient registry data with limited information on outpatient visits. Therefore their cases 
may be more likely to be those with moderate to severe disease leading to slight 
overestimation of the actual risk. In contrast our study provides a more representative picture 
of IBD with disease severity ranging from mild to severe. 
 
Our finding of increased risk of postpartum haemorrhage among those with CD contradicts 
the findings of Broms et al.
24
 This may be due to the difference in study design and 
population studied. For instance, postpartum haemorrhage is more common in the UK 
compared to Sweden (10% versus 6%). Additionally, there is also a marked difference 
between the incidences of caesarean sections between the two counties (17% in Sweden 
versus 26% in the UK) which may be a contributory factor. Our increased risk observed for 
postpartum haemorrhage was however independent of caesarean section.  
 
In conclusion, women with CD are at increased risk of pre-term birth, low birth weight and 
postpartum haemorrhage independent of any effect that either IBD or its complications have 
in increasing caesarean section among these women. In contrast women with UC are only at 
higher risk of pre-term births and for all IBD there was no association with stillbirth. Whilst 
IBD related surgery itself is not associated with the risk of adverse pregnancy related 
complications, it is may be considered an important factor in the decision for elective 
caesarean section especially among those with UC. These findings should be carefully 
considered by women with IBD planning pregnancy and when in clinical consultation with 
pregnant women with IBD. Despite the fact that we have shown significantly increased risks 
for certain pregnancy related complications and adverse birth outcomes particularly among 
those with CD, the absolute differences are small indicating that most women with CD and 
UC will have an uncomplicated pregnancy ending in favourable outcomes. 
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Tables  
Table 1: Descriptive data on singleton births among women diagnosed with 
inflammatory bowel disease and the control population 
  
Variable  Pregnancies among 
women not diagnosed 
with IBD 
(N=362,394) 
Pregnancies among 
women diagnosed with 
IBD 
(N=1,969*) 
Pregnancies among 
women diagnosed 
with CD 
(N=1,002) 
Pregnancies among 
women diagnosed 
with UC 
(N=884) 
 No. % No. % No. % No. % 
Age at delivery**         
15-19 years 21,218 5.9 22 1.1 17 1.7 4 0.5 
20-24 years 62,195 17.2 181 9.2 117 11.7 51 5.8 
25-29 years 95,506 26.4 475 24.1 269 26.8 191 21.6 
30-34 years 110,442 30.5 725 36.8 360 35.9 334 37.8 
35-39 years 60,725 16.8 452 23.0 194 19.4 239 27.0 
40-44 years 12,308 3.4 114 5.8 45 4.5 65 7.4 
         
Body Mass Index**         
Normal(18.5-24.9) 157,950 43.6 1,001 50.8 486 48.5 461 52.1 
Underweight(<18.5) 11,807 3.3 76 3.9 43 4.3 32 3.6 
Overweight(25-29.9) 65,585 18.1 350 17.8 183 18.3 151 17.1 
Obese(>=30) 41,036 11.3 198 10.1 115 11.5 76 8.6 
Missing  86,016 23.7 344 17.5 175 17.5 164 18.6 
         
Smoking status**          
Current smoker 79,650 22.0 370 18.8 257 25.6 97 11.0 
Non-smoker 282,744 78.0 1,599 81.2 745 74.4 787 89.0 
         
Ethnicity**         
White 263,716 72.8 1,629 82.7 847 84.5 713 80.7 
Non-white 37,127 10.2 101 5.1 50 5.0 49 5.5 
Missing 61,551 17.0 239 12.1 105 10.5 122 13.8 
         
Diabetes         
No 351,752 97.1 1,903 96.6 980 97.8 843 95.4 
Yes 10,642 2.9 66 3.4 22 2.2 41 4.6 
         
Calendar year at 
birth** 
        
1997-2001 72,829 20.1 334 17.0 187 18.7 132 14.9 
2002-2006 126,865 35.0 658 33.4 339 33.8 294 33.3 
2007-2012 162,700 44.9 977 49.6 476 47.5 458 51.8 
*Includes Crohn’s disease, Ulcerative colitis and non-specific IBD (n=83). **Statistically significant differences 
between IBD case and controls (p<0.001)
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Table 2: Risk of adverse pregnancy and birth outcome among women diagnosed with 
inflammatory bowel disease 
Outcomes  Controls 
(N=362,394) 
IBD cases* 
(N=1,969) 
CD 
(N=1,002) 
UC 
(N=884) 
 n % n % n % n % 
Pregnancy related complications         
Postpartum haemorrhage 35,197 9.7 229 11.6 123 12.3 97 11.0 
Pre-eclampsia/eclampsia 8,261 2.3 41 2.1 24 2.4 15 1.7 
Antepartum haemorrhage 17,052 4.7 104 5.3 52 5.2 47 5.3 
Venous thromboembolism  567 0.2 8 0.4 3 0.3 5 0.6 
Gestational diabetes  6,667 1.9 46 2.4 14 1.4 29 3.3 
         
Mode of delivery         
Normal vaginal delivery  233,222 64.4 1,093 55.5 539 53.8 508 57.5 
Assisted 43,846 12.1 278 14.1 137 13.7 128 14.5 
Elective caesarean 35,301 9.7 300 15.2 172 17.2 121 13.7 
Emergency caesarean 50,025 13.8 298 15.1 154 15.4 127 14.4 
         
Adverse birth outcomes         
Adverse birth outcomes
1
 31,296 8.6 222 11.3 120 12.0 94 10.6 
Stillbirth
5
 1,566 0.4 10 0.5 5 0.5 4 0.5 
         
Length of gestation         
Normal (37-41 weeks) 304,870 84.1 1,651 83.8 832 83.0 751 85.0 
Pre-term (<37 weeks) 23,525 6.5 170 8.6 91 9.1 75 8.5 
Prolonged (>41 weeks) 33,999 9.4 148 7.5 79 7.9 58 6.6 
         
Birth weight in grams         
2500-4500 grams
δ
 272,232 75.2 1,492 75.9 736 73.5 688 77.9 
>4500 grams  5,283 1.5 24 1.2 7 0.7 15 1.7 
<2500 grams 16,406 4.5 107 5.4 61 6.1 42 4.8 
Missing  68,083 18.8 343 17.4 197 19.7 138 15.6 
Mean birth weight (SD) 3381  (581) 3331 (587) 3301 (589) 3353 (581) 
*Includes Crohn’s disease, Ulcerative colitis and non-specific IBD 
1
Includes pregnancies of women resulting in 
stillbirth, pre-term birth or infant born with low birth weight. SD = Standard deviation. 
δ
Among live births only
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Table 3: Risk of adverse pregnancy and birth outcome among women diagnosed IBD 
compared to controls stratified by Ulcerative colitis and Crohns disease  
 
Variables  IBD CD UC 
 OR* (95% CI) 
Adjusted
1
 
OR* (95% CI) 
Adjusted
1
 
OR* (95% CI) 
Adjusted
1
 
Pregnancy complication     
Postpartum haemorrhage  1.16 (1.00-1.34) 1.27 (1.04-1.55) 1.05 (0.84-1.30) 
Pre-eclampsia/eclampsia 0.95 (0.68-1.33) 1.11 (0.70-1.75) 0.76 (0.46-1.28) 
Antepartum haemorrhage  1.18 (0.97-1.45) 1.14 (0.86-1.51) 1.22 (0.90-1.66) 
Venous thromboembolism  2.48 (1.23-5.00) - 3.49 (1.43-8.47) 
Gestational diabetes  1.21 (0.88-1.67) 0.74 (0.37-1.46) 1.64 (1.12-2.40) 
    
Mode of delivery    
Assisted
3
 1.26 (1.10-1.45) 1.31 (1.08-1.58) 1.21 (0.99-1.48) 
Elective caesarean
3
 1.56 (1.34-1.81) 1.97 (1.61-2.40) 1.24 (0.99-1.56) 
Emergency caesarean
3
 1.20 (1.05-1.38) 1.31 (1.08-1.59) 1.06 (0.86-1.29) 
    
Adverse birth outcomes    
Adverse birth outcomes
4
 1.39 (1.19-1.61) 1.45 (1.18-1.78) 1.33 (1.06-1.67) 
Stillbirth 1.23 (0.66-2.29) 1.17 (0.48-2.81) 1.13 (0.42-3.01) 
    
Length of gestation    
Pre-term (<37 weeks)
5
 1.36 (1.15-1.61) 1.42 (1.12-1.80) 1.34 (1.04-1.73) 
Prolonged (>41 weeks)
5
 0.82 (0.69-0.97) 0.85 (0.67-1.07) 0.73 (0.55-0.95) 
    
Birth weight    
>4500 grams
6
 0.75 (0.49-1.15) 0.45 (0.21-0.95) 1.01 (0.58-1.74) 
<2500 grams
6
 1.27 (1.03-1.56) 1.40 (1.06-1.85) 1.14 (0.82-1.59) 
Missing
6 
 0.99 (0.87-1.12) 1.13 (0.95-1.34) 0.89 (0.73-1.08) 
1
Adjusted for smoking status, age, ethnicity, diabetes, calendar year and BMI 
2
Analysis based on pregnancies not resulting in normal vaginal delivery as the comparison group 
3
Analysis based on normal vaginal delivery as the comparison group 
4
Includes pregnancies of women resulting in stillbirth, pre-term birth or infant born with low birth weight 
5
Analysis based on pregnancies with normal gestational length (37-41 weeks) 
6
Analysis based on pregnancies resulting in live births with baby’s weight between 2500-4500 grams   
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Table 4: Risk of adverse pregnancy and birth outcome among women diagnosed with 
inflammatory bowel disease with surgery prior to the pregnancy compared women 
without prior surgical intervention  
Outcome  Pregnancies of women 
with  no surgical 
intervention for IBD 
before delivery 
(n=1,625) 
Pregnancies of women 
after surgical 
intervention for IBD 
before delivery 
(n=344) 
OR (95% CI) 
(Adjusted
1
) 
 No. % No. %   
Pregnancy related 
complications  
     
Postpartum haemorrhage 186 11.4 43 12.5 1.10 (0.76-1.59) 
Antepartum haemorrhage 88 5.4 16 4.7 0.86 (0.50-1.49) 
Pre-eclampsia/eclampsia 32 2.0 9 2.6 1.37 (0.64-2.93) 
Venous thromboembolism  - - - - - 
Gestational diabetes  41 2.5 5 1.5 0.59 (0.22-1.59) 
      
Mode of delivery      
Assisted
3
 226 13.9 52 15.1 1.53 (1.06-2.22) 
Elective caesarean
3
 202 12.4 98 28.5 3.15 (2.23-4.45) 
Emergency caesarean
3
 247 15.2 51 14.8 1.33 (0.91-1.94) 
      
Birth outcome      
Adverse birth outcome
4
 181 11.1 41 11.9 1.07 (0.74-1.56) 
Still birth 8 0.5 - - - 
      
Length of gestation      
Pre-term (<37 weeks)
5
 137 8.4 33 9.6 1.16 (0.74-1.67) 
Prolonged (>41 weeks)
5
 121 7.4 27 7.8 1.05 (0.67-1.64) 
      
Birth weight      
>4500 grams
6
  18 1.1 6 1.7 1.54 (0.53-4.44) 
<2500 grams
6
 86 5.3 21 6.1 1.20 (0.70-2.04) 
Missing
6
  287 17.7 56 16.3 0.-94 (0.67-1.30) 
1
Adjusted for smoking status, age, ethnicity, diabetes, calendar year and BMI 
2
Analysis based on pregnancies not resulting in normal vaginal delivery  
3
Analysis based on normal vaginal delivery  
4
Includes pregnancies of women resulting in stillbirth, pre-term birth or infant born with low birth weight 
5
Analysis based on pregnancies with normal gestational length (37-41 weeks) 
6
Analysis based on pregnancies resulting in live births with baby’s weight between 2500-4500 grams   
- <3 cases omitted. 
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Figure legends 
Figure 1: Risk of adverse pregnancy and birth outcome among women diagnosed CD 
compared to controls stratified by the mode of delivery (log10 scale). 
Figure 2: Risk of adverse pregnancy and birth outcome among women diagnosed UC 
compared to controls stratified by the mode of delivery on (log10  scale).
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